seroquel xr 400 mg
tzamal bio-pharma ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 400 mg - quetiapine - quetiapine - seroquel xr is indicated for the treatment of schizophrenia .seroquel xr is effective in preventing relapse in stable schizophrenic patients who have been maintained on seroquel xr. seroquel xr is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate.seroquel xr is indicated for the treatment of major depressive episodes in bipolar disorder. seroquel xr is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. seroquel xr is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy (see section 5.1 pharmacodynamic properties). prior to initiating treatment, clinicians should consider the safety profile of seroquel xr (see section 4.4 special warnings and precautions for use).
seroquel xr 150 mg
tzamal bio-pharma ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 150 mg - quetiapine - quetiapine - seroquel xr is indicated for the treatment of schizophrenia. seroquel xr is effective in preventing relapse in stable schizophrenic patients who have been maintained on seroquel xr. seroquel xr is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.seroquel xr is indicated for the treatment of major depressive episodes in bipolar disorder. treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate.seroquel xr is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate.seroquel xr is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy (see section 5.1 pharmacodynamic properties). prior to initiating treatment, clinicians should consider the safety profile of seroquel xr.
anectine 50 mg/ml solution for inj/inf
glaxosmithkline (ireland) limited - suxamethonium chloride - solution for inj/inf - 50 mg/ml - choline derivatives
geroquel 300 mg film-coated tablets
mcdermott laboratories ltd t/a gerard laboratories - quetiapine fumarate - film-coated tablet - 300 milligram(s) - diazepines, oxazepines, thiazepines and oxepines; quetiapine
suxamethonium chloride 50mg/ml solution for injection
mercury pharmaceuticals (ireland) ltd - suxamethonium chloride - solution for injection - 50 milligram(s)/millilitre - choline derivatives; suxamethonium
seroquel xr tablet 200mg
luye pharma (singapore) pte. ltd. - quetiapine fumarate 230.26mg eqv quetiapine - tablet, extended release - 200 mg - quetiapine fumarate 230.26mg eqv quetiapine 200 mg
seroquel xr tablet 300mg
luye pharma (singapore) pte. ltd. - quetiapine fumarate 345.38mg eqv quetiapine - tablet, extended release - 300 mg - quetiapine fumarate 345.38mg eqv quetiapine 300 mg
seroquel xr tablet 400mg
luye pharma (singapore) pte. ltd. - quetiapine fumarate 460.50mg eqv quetiapine - tablet, extended release - 400 mg - quetiapine fumarate 460.50mg eqv quetiapine 400 mg
seroquel xr tablet 50mg
luye pharma (singapore) pte. ltd. - quetiapine fumarate 57.56mg eqv quetiapine - tablet, extended release - 50 mg - quetiapine fumarate 57.56mg eqv quetiapine 50 mg
seroquel tablet 300mg
luye pharma (singapore) pte. ltd. - quetiapine fumarate 345 mg eqv quetiapine (core) - tablet, film coated - 300 mg - quetiapine fumarate 345 mg eqv quetiapine (core) 300 mg